Diagnostic options · UAE

Hearing Loss tests in Dubai & UAE

Compare available Hearing Loss tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Hearing Loss test prices

Showing 1–6 of 6 matching tests.

Hearing Loss diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5685 CCDC50 Gene (Deafness, Autosomal Dominant Type 44) Genetic Test This genetic test analyzes the CCDC50 gene to detect mutations causing autosomal dominant nonsyndromic hearing loss (DFNA44). It uses Next-Generation Sequencing (NGS) for comprehen...	Whole Blood (Peripheral)	21–28 business days (3–4 weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CCDC50 gene sequence", "Single nucleotide variants", "Insertions", "Deletions", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "Avoid recent blood transfusion or bone marrow transplant (within 12 weeks)"] Indications ["Suspected autosomal dominant nonsyndromic hearing loss (DFNA44)", "Family history of DFNA44", "Genetic counseling for hereditary hearing loss"] Measurement technique Confirm with laboratory Codes LOINC: 81287-4 ICD-10: H90.3 Clinical summary This genetic test analyzes the CCDC50 gene to detect mutations causing autosomal dominant nonsyndromic hearing loss (DFNA44). It uses Next-Generation Sequencing (NGS) for comprehensive analysis.
TEST-5761 GRHL2 Gene Autosomal Dominant Deafness Type 28 Genetic Test This test identifies pathogenic variants in the GRHL2 gene, which are associated with autosomal dominant non-syndromic hearing loss (DFNA28). It helps confirm a diagnosis in indivi...	Whole Blood, Buccal Swab, or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GRHL2 gene"] Parameters [] Preparation [] Indications ["Suspected autosomal dominant non-syndromic hearing loss (DFNA28)", "Family history of GRHL2-related hearing loss"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: H90.5 Clinical summary This test identifies pathogenic variants in the GRHL2 gene, which are associated with autosomal dominant non-syndromic hearing loss (DFNA28). It helps confirm a diagnosis in individuals with suspected GRHL2-related hearing loss.
TEST-5652 LOXHD1 Gene Test This diagnostic test evaluates the LOXHD1 gene for pathogenic variants associated with autosomal recessive nonsyndromic hearing loss type 77 (DFNB77).	Whole Blood, Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the LOXHD1 gene", "Coverage of all coding exons and splice-site regions"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Individuals with congenital or early-onset bilateral sensorineural hearing loss of unknown etiology", "Siblings of confirmed DFNB77 patients", "Couples with a family history of consanguinity seeking preconception carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 82638-6 ICD-10: H90.3 Clinical summary This diagnostic test evaluates the LOXHD1 gene for pathogenic variants associated with autosomal recessive nonsyndromic hearing loss type 77 (DFNB77).
TEST-5675 MARVELD2 Gene NGS Test (Autosomal Recessive Deafness Type 49) This test evaluates the MARVELD2 gene for pathogenic variants associated with autosomal recessive sensorineural hearing loss (DFNB49).	Whole Blood, Extracted DNA, or FTA Card	3–4 weeks (expedited available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MARVELD2 gene", "Copy Number Variations (CNVs) in the MARVELD2 gene"] Parameters [] Preparation ["Mandatory pre-test genetic counselling with a DHA-licensed genetic counsellor", "Construction of a three-generation pedigree chart"] Indications ["Individuals with bilateral congenital sensorineural hearing loss", "Individuals from consanguineous families with hearing loss", "Couples planning pregnancy with a family history of deafness", "Siblings of confirmed DFNB49 patients", "Carrier screening in high-risk ethnic groups", "Prenatal diagnosis when both parents are known carriers"] Measurement technique Confirm with laboratory Codes LOINC: 90423-7 ICD-10: H90.3, H90.4, Z14.8 Clinical summary This test evaluates the MARVELD2 gene for pathogenic variants associated with autosomal recessive sensorineural hearing loss (DFNB49).
TEST-5627 POU3F4 Gene X-Linked Deafness Type 2 Genetic Test This test identifies pathogenic variants in the POU3F4 gene associated with X-linked deafness type 2.	Peripheral whole blood or dried blood spot (FTA card)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the POU3F4 gene", "Single nucleotide variants", "Deletions", "Duplications"] Parameters [] Preparation ["No fasting required", "Pre-genetic counselling is mandatory"] Indications ["Diagnosis of X-linked deafness type 2 (DFNX2)", "Family risk assessment for DFNX2", "Personalised management of hearing loss"] Measurement technique Confirm with laboratory Codes LOINC: 92432-6 ICD-10: H90.3 Clinical summary This test identifies pathogenic variants in the POU3F4 gene associated with X-linked deafness type 2.
TEST-5730 TBC1D24 Gene Autosomal Dominant Deafness Type 65 (DFNA65) Genetic Test This test identifies pathogenic variants in the TBC1D24 gene associated with autosomal dominant nonsyndromic hearing loss type DFNA65.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TBC1D24 gene"] Parameters [] Preparation ["No special preparation required", "Do not discontinue prescribed medications without physician approval"] Indications ["Suspected autosomal dominant nonsyndromic hearing loss (DFNA65)", "Genetic counseling for families with hearing loss"] Measurement technique Confirm with laboratory Codes LOINC: 82111-3 ICD-10: Z13.71, H90.3, Z82.2 Clinical summary This test identifies pathogenic variants in the TBC1D24 gene associated with autosomal dominant nonsyndromic hearing loss type DFNA65.

Category overview

Hearing Loss: overview

Discovering unexpected auditory decline or diagnosing congenital deafness in a newborn can be deeply emotional, but pinpointing the exact biological root provides a clear path forward for effective intervention. Representing a critical offering within our specialized Genetics department, Hearing Loss testing evaluates your DNA to differentiate hereditary auditory conditions from environmental factors. Utilizing advanced diagnostic technology, this vital molecular screening helps uncover hidden structural or functional defects within the inner ear, safely guiding personalized audiology care, hearing aid optimization, and early educational support. Recognized for compassionate sensory diagnostics among premier diagnostic labs in Dubai and the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical precision, and prompt, reliable reporting. Support your family's auditory wellness—schedule your hearing loss testing in UAE, coordinate a comfortable home sample collection, or reach out to our dedicated specialists.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.